Emel Akoğlu

986 total citations
28 papers, 669 citations indexed

About

Emel Akoğlu is a scholar working on Surgery, Nephrology and Molecular Biology. According to data from OpenAlex, Emel Akoğlu has authored 28 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Nephrology and 4 papers in Molecular Biology. Recurrent topics in Emel Akoğlu's work include Dialysis and Renal Disease Management (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Muscle and Compartmental Disorders (3 papers). Emel Akoğlu is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Muscle and Compartmental Disorders (3 papers). Emel Akoğlu collaborates with scholars based in Türkiye, Belgium and United States. Emel Akoğlu's co-authors include Çeti̇n Özener, Azra Bihorac, Turgay İşbir, Hülya Yılmaz, Bedia Ağaçhan, Ekrem Erek, Mehmet Şükrü Sever, Serhan Tuğlular, Hülya Ergin and Mahmut Yavuz and has published in prestigious journals such as Kidney International, Clinical Chemistry and American Journal of Kidney Diseases.

In The Last Decade

Emel Akoğlu

27 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emel Akoğlu Türkiye 13 252 205 193 107 97 28 669
A. Cantaluppi Italy 15 220 0.9× 229 1.1× 600 3.1× 66 0.6× 126 1.3× 58 890
Brian J. Carrie United States 10 147 0.6× 89 0.4× 453 2.3× 124 1.2× 131 1.4× 11 645
Shvan Korsheed United Kingdom 6 269 1.1× 173 0.8× 564 2.9× 298 2.8× 131 1.4× 9 894
R.T. Krediet Netherlands 11 165 0.7× 129 0.6× 490 2.5× 50 0.5× 88 0.9× 19 609
R. Vanholder Belgium 11 139 0.6× 71 0.3× 492 2.5× 87 0.8× 85 0.9× 14 874
Pirouz Daeihagh United States 9 84 0.3× 93 0.5× 142 0.7× 56 0.5× 84 0.9× 10 446
Juan P. Bosch United States 11 103 0.4× 56 0.3× 421 2.2× 63 0.6× 145 1.5× 29 696
George E. Digenis Canada 15 163 0.6× 102 0.5× 370 1.9× 26 0.2× 131 1.4× 34 552
Gavin I. Russell United Kingdom 10 378 1.5× 276 1.3× 864 4.5× 75 0.7× 166 1.7× 17 1.1k
Taner Baştürk Türkiye 15 119 0.5× 62 0.3× 397 2.1× 83 0.8× 105 1.1× 75 717

Countries citing papers authored by Emel Akoğlu

Since Specialization
Citations

This map shows the geographic impact of Emel Akoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emel Akoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emel Akoğlu more than expected).

Fields of papers citing papers by Emel Akoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emel Akoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emel Akoğlu. The network helps show where Emel Akoğlu may publish in the future.

Co-authorship network of co-authors of Emel Akoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Emel Akoğlu. A scholar is included among the top collaborators of Emel Akoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emel Akoğlu. Emel Akoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arikan, Hakkı, Halil Tuğtepe, Fulya Çakalağaoğlu, et al.. (2014). Cysteinyl 1 Receptor Antagonist Montelukast, Does Not Prevent Peritoneal Membrane Damage in Experimental Chronic Peritoneal Dialysis Model in Rats. Kidney & Blood Pressure Research. 39(6). 648–657. 3 indexed citations
2.
Kaygusuz, Işık, Mehmet Koç, Hakkı Arikan, et al.. (2010). Focal Segmental Glomerulosclerosis Associated with Idiopathic Myelofibrosis. Renal Failure. 32(2). 273–276. 8 indexed citations
3.
4.
Arikan, Hakkı, Mehmet Koç, Serhan Tuğlular, Çeti̇n Özener, & Emel Akoğlu. (2009). Elevated Plasma Levels of PAI-1 Predict Cardiovascular Events and Cardiovascular Mortality in Prevalent Peritoneal Dialysis Patients. Renal Failure. 31(6). 438–445. 8 indexed citations
5.
Arikan, Hakkı, Mehmet Koç, Fulya Çakalağaoğlu, et al.. (2008). Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis. Journal of Nephrology. 21(5). 713–721. 15 indexed citations
6.
7.
Erdıl, Tanju Yusuf, Fuat Dede, Serhan Tuğlular, et al.. (2006). Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function. Nuclear Medicine Communications. 27(2). 191–196. 1 indexed citations
8.
Şahin, Sinan, et al.. (2005). Renal artery stenting in solitary functioning kidneys: Technical and clinical results. European Journal of Radiology. 57(1). 131–137. 9 indexed citations
9.
Atagündüz, Pamir, Serhan Tuğlular, Gülçin Kantarcı, Emel Akoğlu, & Haner Di̇reskeneli̇. (2004). Association of FMF-Related (MEFV) Point Mutations with Secondary and FMF Amyloidosis. Nephron Clinical Practice. 96(4). c131–c135. 15 indexed citations
10.
Erek, Ekrem, Mehmet Şükrü Sever, Emel Akoğlu, et al.. (2004). Cost of renal replacement therapy in Turkey. Nephrology. 9(1). 33–38. 31 indexed citations
11.
Yavuz, Di̇lek Gogas, et al.. (2003). Effects of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney. Prostaglandins Leukotrienes and Essential Fatty Acids. 69(4). 223–227. 24 indexed citations
12.
Ağaçhan, Bedia, Turgay İşbir, Hülya Yılmaz, & Emel Akoğlu. (2003). Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Experimental & Molecular Medicine. 35(6). 545–549. 93 indexed citations
13.
Koç, Mehmet, et al.. (2002). QT Dispersion in Renal Transplant Recipients. ˜The œNephron journals/Nephron journals. 91(2). 250–254. 8 indexed citations
14.
Kantarcı, Gülçin, Raymond Vanholder, Serhan Tuğlular, et al.. (2002). Acute renal failure due to crush syndrome during Marmara earthquake. American Journal of Kidney Diseases. 40(4). 682–689. 42 indexed citations
15.
Gönlüşen, Gülfiliz, et al.. (2001). Smooth Muscle Actin (SMA) Immunoreactivity in Primary Glomerulonephritis (GN). TURKISH JOURNAL OF MEDICAL SCIENCES. 31(2). 111–116. 1 indexed citations
16.
Sever, Mehmet Şükrü, Ekrem Erek, Raymond Vanholder, et al.. (2001). The Marmara earthquake: Epidemiological analysis of the victims with nephrological problems. Kidney International. 60(3). 1114–1123. 110 indexed citations
17.
Koç, Mehmet, Azra Bihorac, Çeti̇n Özener, Gülçin Kantarcı, & Emel Akoğlu. (2000). Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim-sulfamethoxazole. American Journal of Kidney Diseases. 36(3). e18.1–e18.6. 15 indexed citations
18.
Yenicesu, Müjdat, Abdülgaffar Vural, Cengiz Utaş, et al.. (1998). Nonrelated Living-Donor Kidney Transplantation: Medical and Ethical Aspects. ˜The œNephron journals/Nephron journals. 79(4). 447–451. 14 indexed citations
19.
Alpdoğan, Önder, et al.. (1995). The Effect of 1,25 Dihydroxyvitamin D3 on Lymphocyte Transformation in Patients with Chronic Renal Failure.. Internal Medicine. 34(4). 240–242. 2 indexed citations
20.
Çeti̇ner, Sali̇h, et al.. (1989). Immunological studies in sickle cell disease: Comparison of homozygote mild and severe variants. Clinical Immunology and Immunopathology. 53(1). 32–39. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Cantaluppi Breakdown of academic impact, for papers by Brian J. Carrie Breakdown of academic impact, for papers by Shvan Korsheed Breakdown of academic impact, for papers by R.T. Krediet Breakdown of academic impact, for papers by R. Vanholder Breakdown of academic impact, for papers by Pirouz Daeihagh Breakdown of academic impact, for papers by Juan P. Bosch Breakdown of academic impact, for papers by George E. Digenis Breakdown of academic impact, for papers by Gavin I. Russell Breakdown of academic impact, for papers by Taner Baştürk
Rankless by CCL
2026